Symptomtext
temperature excursion for the following unopen products: QUADRACEL, DAPTACEL, PENTACEL, and TUBERSOL with no reported adverse event; Initial information received on 10-Jan-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown demographics who had temperature excursion for the following unopen products: quadracel, daptacel, pentacel, and tubersol with no reported adverse event while receiving vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] and while treated with TUBERCULIN PPD [TUBERSOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking TUBERSOL (TUBERCULIN PPD) Unknown dosage unknown route unknown (lot - C5735AA). On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C5862BA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5816AA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ597AAA in unknown administration site. On 07-JAN-2022 the patient had a non-serious temperature excursion for the following unopen products: quadracel, daptacel, pentacel, and tubersol with no reported adverse event (product temperature excursion issue) (unknown latency) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (temperature excursion for the following unopen products: QUADRACEL, DAPTACEL, PENTACEL, and TUBERSOL with no reported adverse event). At time of reporting, the outcome was Unknown for the event temperature excursion for the following unopen products: quadracel, daptacel, pentacel, and tubersol with no reported adverse event.